Key facts
- OptiMedis’s last known valuation is $8.2M (Aug 2017).
- It has raised $1.8M; the latest was Later Stage VC ($860K) in Sep 2025.
- Notable investors include BonVenture.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for OptiMedis
- ·The full record, as it builds
Funding rounds
No funding rounds for OptiMedis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OptiMedis
Developer of a healthcare management platform designed for sickness funds and the healthcare industry to deliver integrated care and improve health outcomes. The company's platform offers regional integrated healthcare systems in which doctors, therapists, hospitals, pharmacies, and other partners work in association and overcome past constraints, enabling users to receive healthcare benefits while reducing insurance costs.
- Sector
- Healthcare
- HQ
- Hamburg, Germany
- Founded
- 2003
- Employees
- 26
- Website
- optimedis.de/
- Ownership
- Privately Held (backing)
OptiMedis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OptiMedis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OptiMedis in its N-PORT filings yet. We sweep new filings monthly.